Intuitive Surgical Inc. (ISRG) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 21, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ISRG SEC filings page.
Intuitive Surgical Inc. (ISRG) reported $11.0B in revenue over the twelve months to Jun 30, 2026, up 20.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue scale is translating into expanding operating profit, stronger cash conversion, and a lightly leveraged balance sheet.
From FY2023 to FY2025, free-cash-flow margin rose from10.5% to24.8% . Operating margin also widened from24.8% to29.3% , linking the cash improvement to better earnings conversion rather than sales scale alone.
FY2025 revenue reached
Capital expenditures fell from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Intuitive Surgical Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Intuitive Surgical Inc. has an operating margin of 29.3%, meaning the company retains $29 of operating profit per $100 of revenue. This strong profitability earns a score of 94/100, reflecting efficient cost management and pricing power. This is up from 28.1% the prior year.
Intuitive Surgical Inc.'s revenue surged 20.5% year-over-year to $10.1B, reflecting rapid business expansion. This strong growth earns a score of 81/100.
Intuitive Surgical Inc. carries a low D/E ratio of 0.14, meaning only $0.14 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 78/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 4.87, Intuitive Surgical Inc. holds $4.87 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 91/100.
Intuitive Surgical Inc. converts 24.8% of revenue into free cash flow ($2.5B). This strong cash generation earns a score of 85/100.
Intuitive Surgical Inc. earns a strong 16.0% return on equity (ROE), meaning it generates $16 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 85/100. This is up from 14.1% the prior year.
Intuitive Surgical Inc. scores 32.99, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($130.4B) relative to total liabilities ($2.5B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Intuitive Surgical Inc. passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Intuitive Surgical Inc. generates $1.06 in operating cash flow ($3.0B OCF vs $2.9B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Intuitive Surgical Inc. generated $2.9B in revenue in Q2 2026. This represents an increase of 18.5% from the same quarter a year earlier. Against the prior quarter it is up 4.4%.
Intuitive Surgical Inc. reported $818.1M in net income in Q2 2026. This represents an increase of 24.3% from the same quarter a year earlier. Against the prior quarter it is down 0.4%.
Intuitive Surgical Inc. earned $2.29 per diluted share (EPS) in Q2 2026. This represents an increase of 26.5% from the same quarter a year earlier. Against the prior quarter it is up 0.4%.
Not reported for Q2 2026.
Cash & Balance Sheet
Intuitive Surgical Inc. generated $948.4M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 69.3% from the same quarter a year earlier. Against the prior quarter it is up 17.3%.
Intuitive Surgical Inc. held $2.8B in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Intuitive Surgical Inc.'s gross margin was 67.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.
Intuitive Surgical Inc.'s operating margin was 33.6% in Q2 2026, reflecting core business profitability. This is up 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.7 percentage points.
Intuitive Surgical Inc.'s net profit margin was 28.3% in Q2 2026, showing the share of revenue converted to profit. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.
Intuitive Surgical Inc.'s ROE was 4.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.
Capital Allocation
Intuitive Surgical Inc. invested $370.6M in research and development in Q2 2026. This represents an increase of 18.3% from the same quarter a year earlier. Against the prior quarter it is up 2.4%.
Intuitive Surgical Inc. spent $320.3M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 77.0% from the same quarter a year earlier. Against the prior quarter it is down 71.5%.
Intuitive Surgical Inc. invested $112.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 27.5% from the same quarter a year earlier. Against the prior quarter it is up 9.0%.
ISRG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9B+18.5% | $2.8B+23.0% | $2.9B+18.8% | $2.5B+22.9% | $2.4B+21.4% | $2.3B+19.2% | $2.4B+25.2% | $2.0B+16.9% |
| Cost of Revenue | $931.9M+13.4% | $940.3M+18.2% | $961.9M+24.7% | $842.7M+26.9% | $822.1M+29.0% | $795.7M+23.3% | $771.3M+18.5% | $664.2M+15.2% |
| Gross Profit | $2.0B+21.2% | $1.8B+25.6% | $1.9B+16.0% | $1.7B+21.0% | $1.6B+17.9% | $1.5B+17.0% | $1.6B+28.6% | $1.4B+17.7% |
| R&D Expenses | $370.6M+18.3% | $361.9M+14.5% | $352.9M+19.7% | $329.4M+15.2% | $313.3M+11.9% | $316.2M+11.1% | $294.7M+13.3% | $286.0M+14.7% |
| SG&A Expenses | $617.9M+10.1% | $613.3M+8.9% | $687.1M+12.2% | $573.3M+12.3% | $561.2M+6.8% | $563.4M+14.6% | $612.6M+8.0% | $510.6M+13.0% |
| Operating Income | $971.9M+30.7% | $855.3M+48.0% | $864.3M+17.6% | $759.7M+31.6% | $743.4M+31.0% | $578.1M+23.2% | $734.9M+63.2% | $577.3M+23.9% |
| Income Tax | $231.4M+37.8% | $114.4M+425.0% | $156.1M+28.2% | $146.0M+45.4% | $167.9M+36.5% | -$35.2M-295.5% | $121.8M+228.5% | $100.4M-1.8% |
| Net Income | $818.1M+24.3% | $821.5M+17.6% | $794.8M+15.9% | $704.4M+24.7% | $658.4M+25.0% | $698.4M+28.2% | $685.7M+13.1% | $565.1M+35.9% |
| EPS (Basic) | $2.31+25.5% | $2.31+18.5% | $2.23+15.5% | $1.98+24.5% | $1.84+24.3% | $1.95+26.6% | $1.93+12.2% | $1.59+34.7% |
| EPS (Diluted) | $2.29+26.5% | $2.28+18.7% | $2.20+16.4% | $1.95+25.0% | $1.81+24.0% | $1.92+27.2% | $1.89+11.8% | $1.56+34.5% |
| Diluted Shares (Avg) | 357M-1.9% | 360M-1.3% | N/A | 362M-0.2% | 364M+0.9% | 365M+1.1% | N/A | 363M+1.3% |
Not reported in any period shown, so not listed: EBITDA, Interest Expense.
ISRG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.9B+3.5% | $20.1B+4.6% | $20.5B+9.2% | $19.4B+9.1% | $20.2B+21.1% | $19.2B+21.4% | $18.7B+21.4% | $17.7B+20.6% |
| Current Assets | $9.5B+9.1% | $8.8B+15.0% | $9.8B+37.5% | $8.5B+18.2% | $8.7B+14.3% | $7.7B+0.3% | $7.1B-9.9% | $7.2B-19.0% |
| Cash & Equivalents | $2.8B-18.9% | $2.0B-22.0% | $3.4B+66.1% | $2.8B+16.3% | $3.4B+12.1% | $2.6B-9.4% | $2.0B-26.3% | $2.4B-33.0% |
| Short-Term Investments | $2.5B+27.7% | $2.5B+29.6% | $2.6B+29.3% | $2.1B+15.6% | $1.9B+11.8% | $1.9B-1.2% | $2.0B-19.7% | $1.8B-36.7% |
| Inventory | $2.0B+21.7% | $1.9B+25.2% | $1.8B+23.7% | $1.8B+20.3% | $1.7B+20.5% | $1.6B+19.6% | $1.5B+21.8% | $1.5B+29.1% |
| Accounts Receivable | $1.7B+31.8% | $1.6B+30.6% | $1.5B+24.6% | $1.3B+9.3% | $1.3B+14.4% | $1.2B+8.3% | $1.2B+8.4% | $1.2B+19.8% |
| Long-Term Investments | $3.4B-18.9% | $3.5B-24.6% | $3.1B-35.7% | $3.5B-13.6% | $4.2B+43.8% | $4.6B+82.0% | $4.8B+127.3% | $4.1B+290.4% |
| Goodwill | $580.6M+66.5% | $613.2M+76.5% | $370.3M+6.6% | $348.1M-0.1% | $348.7M+0.2% | $347.5M-0.2% | $347.5M-0.3% | $348.3M+0.1% |
| Total Liabilities | $2.6B+16.7% | $2.5B+24.9% | $2.5B+13.7% | $2.3B+11.8% | $2.2B+19.2% | $2.0B+13.0% | $2.2B+8.3% | $2.1B-1.1% |
| Current Liabilities | $1.9B+13.6% | $1.9B+24.2% | $2.0B+14.9% | $1.8B+7.5% | $1.7B+13.8% | $1.5B+11.9% | $1.7B+5.2% | $1.7B0.0% |
| Non-Current Liabilities | $656.0M+26.8% | $602.8M+27.0% | $510.8M+9.1% | $506.5M+30.2% | $517.5M+41.4% | $474.6M+16.8% | $468.3M+21.5% | $389.1M-5.7% |
| Total Equity | $18.2B+1.8% | $17.5B+2.2% | $17.8B+8.5% | $16.9B+8.6% | $17.8B+21.3% | $17.1B+22.5% | $16.4B+23.5% | $15.6B+24.3% |
| Retained Earnings | $6.8B-10.1% | $6.4B-10.4% | $7.0B+3.1% | $6.4B+4.8% | $7.6B+36.3% | $7.1B+40.9% | $6.8B+43.4% | $6.1B+45.6% |
Not reported in any period shown, so not listed: Long-Term Debt.
ISRG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B+48.3% | $911.9M+56.8% | $892.5M+8.5% | $841.0M+19.0% | $715.4M+15.3% | $581.6M+119.1% | $822.6M+260.3% | $706.5M+28.8% |
| Stock-Based Compensation | $212.8M+6.5% | $209.5M+13.1% | N/A | $206.0M+17.2% | $199.9M+13.3% | $185.2M+20.8% | N/A | $175.8M+11.9% |
| Capital Expenditures | $112.6M-27.5% | $103.3M-11.4% | $162.5M-47.9% | $105.4M-57.5% | $155.3M-49.8% | $116.6M-51.8% | $312.0M-28.4% | $247.9M-3.3% |
| Free Cash Flow | $948.4M+69.3% | $808.6M+73.9% | $730.0M+43.0% | $735.6M+60.4% | $560.1M+80.0% | $465.0M+1878.7% | $510.6M+346.4% | $458.6M+57.0% |
| Investing Cash Flow | -$26.6M-110.2% | -$914.5M-528.3% | -$209.4M+83.4% | $401.0M+128.4% | $260.7M+155.8% | $213.5M+266.1% | -$1.3B-21.1% | -$1.4B-216.4% |
| Financing Cash Flow | -$287.9M-94.8% | -$1.4B-474.1% | -$137.5M-378.3% | -$1.8B-1976.8% | -$147.8M-395.6% | -$235.8M-404.9% | $49.4M+256.8% | $98.2M+58.9% |
| Dividends Paid | N/A | N/A | N/A | $0 | N/A | N/A | N/A | $0 |
| Share Buybacks | $320.3M+77.0% | $1.1B | $201.0M | $1.9B | $181.0M | $0 | $0-100.0% | $0 |
Not reported in any period shown, so not listed: Depreciation & Amortization.
ISRG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.8%+1.5pp | 66.1%+1.4pp | 66.4%-1.6pp | 66.4%-1.1pp | 66.3%-2.0pp | 64.7%-1.2pp | 68.0%+1.8pp | 67.4%+0.5pp |
| Operating Margin | 33.6%+3.1pp | 30.9%+5.2pp | 30.1%-0.3pp | 30.3%+2.0pp | 30.5%+2.2pp | 25.7%+0.8pp | 30.4%+7.1pp | 28.3%+1.6pp |
| Net Margin | 28.3%+1.3pp | 29.6%-1.3pp | 27.7%-0.7pp | 28.1%+0.4pp | 27.0%+0.8pp | 31.0%+2.2pp | 28.4%-3.0pp | 27.7%+3.9pp |
| Return on Equity | 4.5%+0.8pp | 4.7%+0.6pp | 4.5%+0.3pp | 4.2%+0.5pp | 3.7%+0.1pp | 4.1%+0.2pp | 4.2%-0.4pp | 3.6%+0.3pp |
| Return on Assets | 3.9%+0.6pp | 4.1%+0.5pp | 3.9%+0.2pp | 3.6%+0.5pp | 3.3%+0.1pp | 3.6%+0.2pp | 3.7%-0.3pp | 3.2%+0.4pp |
| Current Ratio | 4.96-0.2x | 4.61-0.4x | 4.87+0.8x | 4.73+0.4x | 5.170.0x | 4.98-0.6x | 4.07-0.7x | 4.30-1.0x |
| Debt-to-Equity | 0.140.0x | 0.140.0x | 0.140.0x | 0.140.0x | 0.120.0x | 0.120.0x | 0.130.0x | 0.130.0x |
| Asset Turnover | 0.140.0x | 0.140.0x | 0.140.0x | 0.130.0x | 0.120.0x | 0.120.0x | 0.130.0x | 0.110.0x |
| FCF Margin | 32.8%+9.8pp | 29.2%+8.5pp | 25.5%+4.3pp | 29.4%+6.9pp | 22.9%+7.5pp | 20.6%+19.4pp | 21.2%+31.9pp | 22.5%+5.8pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. ISRG | FY2025 | $10.1B | $2.9B | 28.4% | $130.4B | 86/100 |
| Becton, Dickinson and Co. BDX | FY2025 | $21.8B | $1.7B | 7.7% | $48.4B | 52/100 |
| ResMed Inc. RMD | FY2026 | $5.7B | $1.5B | 26.9% | $31.5B | 87/100 |
| Alcon Inc. ALC | FY2010 | $7.2B | $2.2B | 30.8% | $31.9B | — |
| Hologic Inc HOLX | FY2025 | $4.1B | $565.7M | 13.8% | $17.0B | 68/100 |
| West Pharmaceutical Services, Inc. WST | FY2025 | $3.1B | $493.7M | 16.1% | $24.4B | 76/100 |
Where Intuitive Surgical Inc. Ranks
Frequently Asked Questions
What is Intuitive Surgical Inc.'s annual revenue?
Intuitive Surgical Inc. (ISRG) reported $10.1B in total revenue for fiscal year 2025. This represents a 20.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Intuitive Surgical Inc.'s revenue growing?
Intuitive Surgical Inc. (ISRG) revenue grew by 20.5% year-over-year, from $8.4B to $10.1B in fiscal year 2025.
Is Intuitive Surgical Inc. profitable?
Yes, Intuitive Surgical Inc. (ISRG) reported a net income of $2.9B in fiscal year 2025, with a net profit margin of 28.4%.
What is Intuitive Surgical Inc.'s EBITDA?
Intuitive Surgical Inc. (ISRG) had EBITDA of $3.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Intuitive Surgical Inc.'s gross margin?
Intuitive Surgical Inc. (ISRG) had a gross margin of 66.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Intuitive Surgical Inc.'s operating margin?
Intuitive Surgical Inc. (ISRG) had an operating margin of 29.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Intuitive Surgical Inc.'s net profit margin?
Intuitive Surgical Inc. (ISRG) had a net profit margin of 28.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Intuitive Surgical Inc.'s return on equity (ROE)?
Intuitive Surgical Inc. (ISRG) has a return on equity of 16.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Intuitive Surgical Inc.'s free cash flow?
Intuitive Surgical Inc. (ISRG) generated $2.5B in free cash flow during fiscal year 2025. This represents a 91.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Intuitive Surgical Inc.'s operating cash flow?
Intuitive Surgical Inc. (ISRG) generated $3.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Intuitive Surgical Inc.'s total assets?
Intuitive Surgical Inc. (ISRG) had $20.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Intuitive Surgical Inc.'s capital expenditures?
Intuitive Surgical Inc. (ISRG) invested $539.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Intuitive Surgical Inc. spend on research and development?
Intuitive Surgical Inc. (ISRG) invested $1.3B in research and development during fiscal year 2025.
What is Intuitive Surgical Inc.'s current ratio?
Intuitive Surgical Inc. (ISRG) had a current ratio of 4.87 as of fiscal year 2025, which is generally considered healthy.
What is Intuitive Surgical Inc.'s debt-to-equity ratio?
Intuitive Surgical Inc. (ISRG) had a debt-to-equity ratio of 0.14 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Intuitive Surgical Inc.'s return on assets (ROA)?
Intuitive Surgical Inc. (ISRG) had a return on assets of 14.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Intuitive Surgical Inc.'s P/E ratio?
Intuitive Surgical Inc. (ISRG) trades at 41.5x earnings, its market capitalization divided by net income of $3.1B net income, trailing 12 months to June 30, 2026. The market capitalization is $130.4B as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Intuitive Surgical Inc.'s price-to-sales ratio?
Intuitive Surgical Inc. (ISRG) trades at 11.8x sales, its market capitalization divided by revenue of $11.0B revenue, trailing 12 months to June 30, 2026. The market capitalization is $130.4B as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Intuitive Surgical Inc.'s Altman Z-Score?
Intuitive Surgical Inc. (ISRG) has an Altman Z-Score of 32.99, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Intuitive Surgical Inc.'s Piotroski F-Score?
Intuitive Surgical Inc. (ISRG) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Intuitive Surgical Inc.'s earnings high quality?
Intuitive Surgical Inc. (ISRG) has an earnings quality ratio of 1.06x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Intuitive Surgical Inc.?
Intuitive Surgical Inc. (ISRG) scores 86 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.